Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Aurora fire lieutenant outlines leave‑behind Narcan pilot and follow‑up plan
Loading...
Summary
Aurora Fire Rescue presented a pilot program to leave overdose reversal kits with patients or companions after on‑scene Narcan administration and to use QR‑code tracking for follow‑up; committee members endorsed moving the idea forward while debating public dispensing and resource capacity.
Jack Thompson, a lieutenant and community health officer with Aurora Fire Rescue (speaker 8), told the Public Safety and Civil Service Committee that the department will pilot a “leave‑behind” Narcan program to provide opioid reversal kits to people treated on scene and to follow up afterward.
Thompson said crews will carry multiple kits, that the kits include QR codes linking to bilingual how‑to videos and resource lists, and that the department will document kit distribution in patient‑care reports and a SharePoint log so the community health officer can attempt outreach within one to two days. “Because if they die, they can never recover,” Thompson said, arguing that the program’s immediate aim is to prevent deaths and connect survivors to services.
Dr. Hill (speaker 11) described Narcan as an opioid antagonist that reverses opioid‑related respiratory depression and said it is safe to administer even if the person is not taking opioids. “Narcan is just an opiate reversal agent… it basically blocks that and reopens up that (airway),” Dr. Hill said.
Thompson told the committee the supply will come through a state purchase fund and Aurora Fire Rescue (the transcript references 'AFR'); he said crews will initially place about five boxes of kits on each engine and ladder and more on battalion‑level units, with extras stored at stations and restocked as used. A QR scan will generate a protected patient‑care report that the community health officer will use for outreach and potential referrals to AMRT and other services.
Committee members asked for clarifications about distribution and community exposure. One member raised concerns about public dispensing (for example, placing kits in newspaper racks), calling that approach an “enabler” that could concentrate drug use in public places; others said the leave‑behind model combined with follow‑up shifts the intervention to a controlled, data‑driven approach that can identify hotspots and link people to treatment.
The presentation included local statistics (as stated by the presenter) on opioid overdoses and on‑scene Narcan administrations; transcript formatting made some numbers unclear, so specific counts are reported in the meeting record and are summarized in the committee’s materials rather than restated here verbatim. Thompson said the pilot is free to the city through the state program and that the department will track distributions and refusals to assess impact.
The committee signaled support for moving the pilot forward and asked staff to return with additional operational numbers and implementation details; no formal council vote was recorded at the meeting.
Next steps: staff will proceed with the pilot and return to the committee with clarified counts, funding/source documentation and follow‑up metrics for review.
